N
Newcells Biotech
Experts in the production of induced pluripotent stem cells
About Newcells Biotech
Newcells Biotech is a pioneering company specializing in the development of advanced stem cell technology for drug discovery and disease modeling. The company serves pharmaceutical and biotechnology firms by providing highly predictive human cell-based assays, which are crucial for testing the efficacy and safety of new drugs. Operating in the life sciences market, Newcells Biotech employs a business-to-business (B2B) model, generating revenue through the sale of its proprietary cell-based assays and related services. By leveraging cutting-edge stem cell research, the company helps its clients reduce the time and cost associated with drug development, thereby accelerating the path to market for new therapeutics.
Source: Dealroom company dataAt a glance
- Founded
- 2014
- Headquarters
- Newcastle upon Tyne, United Kingdom
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
NVM private equity
Northstar Ventures
Northstar
Series A3 investors entered at this stage
European Regional Development Fund
Mercia Asset Management- NFNorth East Venture Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Newcells Biotech on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Newcells Biotech on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.